Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04002141 · ClinicalTrials.gov registry record · Phase 2
Assessment and Prevention of Pain During Ovarian Stimulation in Patients With Endometriosis
A Phase 2 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
NCT04002141 is a Phase 2 study that has completed, run by University of California, San Francisco. The registered enrollment target is 60 participants.
The verdict
NCT04002141, a Phase 2 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
Study Summary
Randomized double blinded placebo-controlled trial to evaluate the impact of ovarian hyperstimulation on endometriosis-related symptoms and to evaluate the impact of letrozole use during ovarian hyperstimulation with respect to endometriosis-related symptoms, embryo/egg quality and quantity, and pregnancy rates.
Interventions
- DRUG Letrozole
- DRUG Placebo oral tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2019-09-17 |
| Est. Completion | 2025-01-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04002141
The ClinicalTrials.gov registry entry for NCT04002141 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Letrozole is the first listed.
NCT04002141 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04002141 about?
NCT04002141 is a clinical study titled "Assessment and Prevention of Pain During Ovarian Stimulation in Patients With Endometriosis". Randomized double blinded placebo-controlled trial to evaluate the impact of ovarian hyperstimulation on endometriosis-related symptoms and to evaluate the impact of letrozole use during ovarian hyperstimulation with respect to endometriosis-related symptoms, embryo/egg quality and quantity, and pre...
What is the current status of trial NCT04002141?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2019-09-17. Estimated completion is 2025-01-01.
What interventions are being tested in trial NCT04002141?
The interventions under investigation include: Letrozole (DRUG), Placebo oral tablet (DRUG).
Who is sponsoring clinical trial NCT04002141?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.